Restructuring charges: we incur restructuring and impairment charges on individual or groups of employed assets, which arise from unforeseen circumstances and/or often occur outside of the ordinary course of our on-going business. Although these events are reflected in our GAAP financials, these unique transactions may limit the comparability of our on-going operations with prior and future periods.
Significant litigation charges or benefits and legal costs: we may incur charges or benefits as well as legal costs in connection with litigation and other contingencies unrelated to our core operations. We exclude these charges or benefits, when significant, as well as legal costs associated with significant legal matters, because we do not believe they are reflective of on-going business and operating results.
Income tax expense: we estimate the tax effect of the items identified to determine a non-GAAP annual effective tax rate applied to the pretax amount in order to calculate the non-GAAP provision for income taxes. We also adjust for items for which the nature and/or tax jurisdiction requires the application of a specific tax rate or treatment.
From time to time in the future, there may be other items excluded if we believe that doing so is consistent with the goal of providing useful information to investors and management.
There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. The non-GAAP financial measures are limited in value because they exclude certain items that may have a material impact on our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP in the United States. Investors should review the reconciliation of the non-GAAP financial measures to their most directly comparable GAAP financial measures as provided in the tables accompanying this press release.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”) which include Onto Innovation’s business momentum and future growth; the benefit to customers of Onto Innovation’s products and customer service; Onto Innovation’s ability to both deliver products and services consistent with our customers’ demands and expectations and strengthen its market position; Onto Innovation’s expectations regarding the semiconductor market outlook; Onto Innovation’s first quarter 2021 financial outlook; as well as other matters that are not purely historical data. Onto Innovation wishes to take advantage of the “safe harbor” provided for by the Act and cautions that actual results may differ materially from those projected as a result of various factors, including risks and uncertainties, many of which are beyond Onto Innovation’s control. Such factors include, but are not limited to, the length, severity and potential business impact of the COVID-19 pandemic, the Company’s ability to leverage its resources to improve its position in its core markets; its ability to weather difficult economic environments; its ability to open new market opportunities and target high-margin markets; the strength/weakness of the back-end and/or front-end semiconductor market segments; fluctuations in customer capital spending and any potential impact as a result of the novel coronavirus situation. Additional information and considerations regarding the risks faced by Onto Innovation are available in Onto Innovation’s Form 10-K report for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. As the forward-looking statements are based on Onto Innovation’s current expectations, the Company cannot guarantee any related future results, levels of activity, performance or achievements. Onto Innovation does not assume any obligation to update the forward-looking information contained in this press release.
About Onto Innovation
Onto Innovation is a leader in process control, combining global scale with an expanded portfolio of leading-edge technologies that include: Un-patterned wafer quality; 3D metrology spanning chip features from nanometer scale transistors to large die interconnects; macro defect inspection of wafers and packages; elemental layer composition; overlay metrology; factory analytics; and lithography for advanced semiconductor packaging. Our breadth of offerings across the entire semiconductor value chain helps our customers solve their most difficult yield, device performance, quality, and reliability issues. Onto Innovation strives to optimize customers’ critical path of progress by making them smarter, faster and more efficient. Headquartered in Wilmington, Massachusetts, Onto Innovation supports customers with a worldwide sales and service organization. Additional information can be found at www.ontoinnovation.com.
Source: Onto Innovation Inc.
ONTO INNOVATION INC. |
||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||||
(In thousands) - (Unaudited) |
||||||||
|
|
|
|
|
|
|
||
|
|
December 26, 2020 |
|
|
December 31, 2019 |
|
||
|
|
|
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash, cash equivalents and marketable securities |
|
$ |
373,722 |
|
|
$ |
320,236 |
|
Accounts receivable, net |
|
|
149,251 |
|
|
|
123,656 |
|
Inventories |
|
|
191,217 |
|
|
|
176,134 |
|
Prepaid and other assets |
|
|
17,471 |
|
|
|
21,638 |
|
Total current assets |
|
|
731,661 |
|
|
|
641,664 |
|
Net property, plant and equipment |
|
|
87,950 |
|
|
|
98,420 |
|
Intangibles, net |
|
|
624,989 |
|
|
|
679,101 |
|
Other assets |
|
|
23,572 |
|
|
|
29,395 |
|
Total assets |
|
$ |
1,468,172 |
|
|
$ |
1,448,580 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
$ |
77,258 |
|
|
$ |
53,942 |
|
Other current liabilities |
|
|
42,833 |
|
|
|
31,801 |
|
Total current liabilities |
|
|
120,091 |
|
|
|
85,743 |
|
Other non-current liabilities |
|
|
83,335 |
|
|
|
98,811 |
|
Total liabilities |
|
|
203,426 |
|
|
|
184,554 |
|
Stockholders’ equity |
|
|
1,264,746 |
|
|
|
1,264,026 |
|
Total liabilities and stockholders’ equity |
|
$ |
1,468,172 |
|
|
$ |
1,448,580 |
|
ONTO INNOVATION INC. |
||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
||||||||||||||||||||
(In thousands, except per share amounts) - (Unaudited) |
||||||||||||||||||||
|
|
|
|
|
|
|
||||||||||||||
|
|
Three Months Ended |
|
|
Twelve Months Ended |
|
||||||||||||||
|
|
December 26, |
|
|
September 26, |
|
|
December 31, |
|
|
December 26, |
|
|
December 31, |
|
|||||
|
|
2020 |
|
|
2020 |
|
|
2019* |
|
|
2020 |
|
|
2019* |
|
|||||
Revenue |
|
$ |
155,128 |
|
|
$ |
126,492 |
|
|
$ |
120,558 |
|
|
$ |
556,496 |
|
|
$ |
305,896 |
|
Cost of revenue |
|
|
79,779 |
|
|
|
57,604 |
|
|
|
80,971 |
|
|
|
278,043 |
|
|
|
170,868 |
|
Gross profit |
|
|
75,349 |
|
|
|
68,888 |
|
|
|
39,587 |
|
|
|
278,453 |
|
|
|
135,028 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
21,812 |
|
|
|
19,678 |
|
|
|
16,705 |
|
|
|
84,584 |
|
|
|
48,358 |
|
Sales and marketing |
|
|
11,272 |
|
|
|
11,924 |
|
|
|
12,637 |
|
|
|
48,136 |
|
|
|
28,251 |
|
General and administrative |
|
|
14,889 |
|
|
|
14,358 |
|
|
|
24,320 |
|
|
|
65,310 |
|
|
|
53,017 |
|
Amortization |
|
|
12,665 |
|
|
|
13,646 |
|
|
|
9,284 |
|
|
|
53,746 |
|
|
|
10,445 |
|
Total operating expenses |
|
|
60,638 |
|
|
|
59,606 |
|
|
|
62,946 |
|
|
|
251,776 |
|
|
|
140,071 |
|
Operating income (loss) |
|
|
14,711 |
|
|
|
9,282 |
|
|
|
(23,359 |
) |
|
|
26,677 |
|
|
|
(5,043 |
) |
Interest income, net |
|
|
459 |
|
|
|
544 |
|
|
|
999 |
|
|
|
2,899 |
|
|
|
3,666 |
|
Other (expense) income, net |
|
|
(643 |
) |
|
|
(899 |
) |
|
|
(61 |
) |
|
|
(2,708 |
) |
|
|
780 |
|
Income (loss) before income taxes |
|
|
14,527 |
|
|
|
8,927 |
|
|
|
(22,421 |
) |
|
|
26,868 |
|
|
|
(597 |
) |
Provision (benefit) for income taxes |
|
|
(5,387 |
) |
|
|
836 |
|
|
|
(4,669 |
) |
|
|
(4,157 |
) |
|
|
(2,507 |
) |
Net income (loss) |
|
$ |
19,914 |
|
|
$ |
8,091 |
|
|
$ |
(17,752 |
) |
|
$ |
31,025 |
|
|
$ |
1,910 |
|
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
0.41 |
|
|
$ |
0.17 |
|
|
$ |
(0.41 |
) |
|
$ |
0.63 |
|
|
$ |
0.06 |
|
Diluted |
|
$ |
0.40 |
|
|
$ |
0.16 |
|
|
$ |
(0.41 |
) |
|
$ |
0.63 |
|
|
$ |
0.06 |
|
Weighted average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
48,931 |
|
|
|
48,900 |
|
|
|
43,609 |
|
|
|
49,136 |
|
|
|
29,729 |
|
Diluted |
|
|
49,326 |
|
|
|
49,131 |
|
|
|
43,609 |
|
|
|
49,475 |
|
|
|
30,007 |
|